-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Fy56pqdw1taKDFXf8CDH7HhDqzs2HA3CIlbmGlfeeCd591FHfo9ZGD2i2b+ms+tl whJ4o/RT13jVZ9ZJ7r1ckg== 9999999997-05-012335.txt : 20050321 9999999997-05-012335.hdr.sgml : 20050321 20050321110859 ACCESSION NUMBER: 9999999997-05-012335 CONFORMED SUBMISSION TYPE: REGDEX/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: FILED AS OF DATE: 20050316 DATE AS OF CHANGE: 20050321 EFFECTIVENESS DATE: 20050316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RA Capital Biotech Fund LP CENTRAL INDEX KEY: 0001315082 FILING VALUES: FORM TYPE: REGDEX/A SEC ACT: 1934 Act SEC FILE NUMBER: 021-74043 FILM NUMBER: 05047566 BUSINESS ADDRESS: STREET 1: 111 HUNTINGTON AVE CITY: BOSTON STATE: MA ZIP: 02199 MAIL ADDRESS: STREET 1: 111 HUNTINGTON AVE CITY: BOSTON STATE: MA ZIP: 02199 REGDEX/A 1 9999999997-05-012335.paper AUTO-GENERATED PAPER DOCUMENT This document was generated as part of a paper submission. Please reference the Document Control Number 05047566 for access to the original document. -----END PRIVACY-ENHANCED MESSAGE-----